BackTable / Urology / Podcast / Episode #203

Active Surveillance: A Data-Driven Approach

with Dr. Dan Lin

Recent research is changing how we manage low risk prostate cancer. In this BackTable Urology Podcast episode, Dr. Dan Lin, a urologist at the University of Washington, walks through contemporary diagnosis, surveillance, and management of Grade Group 2 prostate cancer with host Dr. Aditya Bagrodia.

This podcast is supported by:

Veracyte

Be part of the conversation. Put your sponsored messaging on this episode. Learn how.

Active Surveillance: A Data-Driven Approach with Dr. Dan Lin on the BackTable Urology Podcast

Ep 203 Active Surveillance: A Data-Driven Approach with Dr. Dan Lin

00:00 / 01:04

BackTable, LLC (Producer). (2024, December 3). Ep. 203 – Active Surveillance: A Data-Driven Approach [Audio podcast]. Retrieved from https://www.backtable.com

Stay Up To Date

Follow:

Subscribe:

Podcast Contributors

Dr. Aditya Bagrodia

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Dan Lin

Dr. Dan Lin is a urologist at the University of Washington in Seattle, Washington.

Synopsis

The doctors delve into real-world implementation of active surveillance, alongside the use of advanced diagnostics, biopsy methods, and personalized care plans. The conversation highlights the Canary Prostate Active Surveillance Study (PASS) and the prognostic role of biomarkers and genomic testing. Dr. Lin and Dr. Bagrodia also discuss how lifestyle factors such as diet impact cancer progression and how patients can be empowered to manage their disease. Strategies for transitioning patients off surveillance are highlighted. Finally, the two experts discuss insights from recent clinical trials like PIVOT, PROTECT, and SPCG and how they’re impacting prostate cancer management.

Timestamps

00:00 - Introduction
02:54 - Active Surveillance and Canary PASS Data
12:02 - Biopsy Considerations
19:44 - Active Surveillance Protocols
26:58 - Patient Concerns and Risk Reduction
30:52 - Transitioning Off Surveillance
33:39 - Grade Group 2: Treatment vs. Monitoring
46:24 - Surgical Considerations and Node Dissection
49:25 - Future Directions

Resources

Veracyte
https://www.veracyte.com/

The Materials available on BackTable are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Up Next

NMIBC Tumor Board: Upper Tract Challenges with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast

NMIBC Tumor Board: Nuances in Management with Dr. Mark Tyson and Dr. Sarah Psutka on the BackTable Urology Podcast

Enhancing Care Coordination in Bladder Cancer Treatments with Brynn Moore and Meredith Donahue on the BackTable Urology Podcast

How Biomarkers Enhance Precision Medicine in Non-Muscle Invasive Bladder Cancer with Dr. Katie Murray and Dr. Sarah Psutka on the BackTable Urology Podcast

Beyond PSA: The Science Driving Smarter Blood Tests with Dr. Jason Hafron on the BackTable Urology Podcast

Optimizing Bladder Health in BPH Treatment Strategies with Dr. Shawn West on the BackTable Urology Podcast

Articles

Topics

Get in touch!

We want to hear from you. Let us know if you’re interested in partnering with BackTable as a Podcast guest, a sponsor, or as a member of the BackTable Team.